Merck Receives FDA Approval for ISENTRESS , in Combination with Other Antiretroviral Agents, for the Treatment of HIV-1 Infection
Merck , known as MSD outside the United States and Canada announced that the U.S. FDA has approved ISENTRESS® (raltegravir), the company’s integrase inhibitor,...
Stealth BioTherapeutics Granted Fast Track Designation For The Treatment Of Barth Syndrome
Stealth BioTherapeutics (Stealth), a clinical-stage biopharmaceutical company developing therapeutics to treat mitochondrial dysfunction, today announced that the U.S. Food and Drug Administration (FDA) has...
Bristol-Myers Squibb Awards “Golden Tickets” for LabCentral to Neutrolis, Remora Therapeutics
Bristol-Myers Squibb Company and LabCentral, an innovative, shared laboratory space designed as a launchpad for life-sciences and biotech startups, announced that Neutrolis and Remora...
The European Medicines Agency accepts regulatory submission for Tagrisso in 1st-line EGFR-mutated non-small cell lung cancer
AstraZeneca today announced that the EMA has accepted a variation to the Marketing Authorisation Application (MAAv) for Tagrisso (osimertinib), a third-generation, irreversible epidermal growth...
Fresenius Medical Care achieves improved health outcomes and savings in Demonstration Program in the United States
Fresenius Medical Care, the world’s largest provider of dialysis products and services, announced the results from the first performance year from its End Stage...
Intercept Pharmaceuticals Appoints Christian Weyer as Executive Vice President of Research & Development
Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced...
Novartis’ Ultibro® Breezhaler® significantly improved COPD patients’ lung function after direct switch from Seretide®
Novartis announced positive results from the FLASH study examining the safety and efficacy of directly switching chronic obstructive pulmonary disease (COPD) patients from Seretide®(salmeterol/fluticasone)...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...